ProCE Banner Activity

Managing Patients With Myelofibrosis and First-line Treatment Failure

Slideset Download
Download this slideset from a live symposium at ASH 2022 to review current best practices and emerging strategies for treating patients with myelofibrosis who have received previous therapies (including ruxolitinib).

Released: December 09, 2022

Expiration: December 08, 2023

Share

Faculty

Abdulraheem Yacoub

Abdulraheem Yacoub, MD

Professor
The Division of Hematologic Malignancies and Cellular Therapeutics
University of Kansas Medical Center
The University of Kansas Health System
Westwood, Kansas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

AbbVie Inc.

CTI BioPharma Corp., a Sobi Company

Faculty Disclosure

Primary Author

Abdulraheem Yacoub, MD

Professor
The Division of Hematologic Malignancies and Cellular Therapeutics
University of Kansas Medical Center
The University of Kansas Health System
Westwood, Kansas